Ebola in Africa: Latest Update, 22 October 2026
Nigeria’s newly confirmed imported case has added urgency to a regional response already confronting a major outbreak in DR Congo. Here is what the latest verified reports say, with their dates and limitations.
▶ Explore the narrated 3D updateKey takeaways
- The latest CDC update was published on 22 October; its case table covers 21 October 2026.
- Confirmed cumulative cases, active cases and contacts under monitoring are different measures.
- This outbreak involves Bundibugyo virus. Vaccine and treatment statements must refer to that virus specifically.
Confirmed reports, with a clear cutoff
| Country | Confirmed cases | Confirmed deaths | Cutoff and context |
|---|---|---|---|
| DR Congo | 9,704 | 4,687 | 21 October 2026; ongoing outbreak |
| Kenya | 9 | 1 | 21 October 2026 table; cluster linked to an imported case |
| Nigeria | 1 | 0 | 21 October 2026 table; case confirmed 20 October |
| Uganda | 20 | 2 | 21 October 2026 table; historical cumulative reports, no active cases reported |
Source: CDC, Ebola Outbreak: Current Situation, updated 22 October 2026, table cutoff 21 October. These are incomplete, cumulative confirmed reports. DR Congo’s suspected cases are excluded pending investigation and standardisation. Uganda also has one probable case and one probable death, excluded from the confirmed columns above. Deaths are included within cases; do not add the columns or interpret them as a personal fatality risk. This selected African-country table is not a global total.
What changed in Nigeria?
WHO and Nigeria’s health ministry confirmed an imported Bundibugyo case in the Federal Capital Territory on 20 October. The patient was receiving care in isolation. Authorities initially identified 44 contacts for follow-up. That is a dated contact-tracing figure, not 44 infections.
The patient had recently travelled from Uganda, but WHO said the likely source of infection and full exposure history were still under investigation. Travel history alone does not establish where infection occurred. Uganda’s historical cases should not be mistaken for current active cases.
Why does the virus type matter?
The WHO vaccine Q&A of 9 September says no vaccine is licensed specifically for Bundibugyo disease. Ervebo is licensed for disease caused by Ebola virus, a different virus. Its ability to protect humans against Bundibugyo has not been established; WHO discusses its evaluation within research arrangements.
The WHO outbreak report of 8 October also states that no approved specific treatment exists for Bundibugyo disease. This does not mean no care is available: early supportive care can improve survival.
What is happening in the response?
WHO’s 22 October border report describes stronger surveillance and coordination between DR Congo and South Sudan. It is a preparedness report, not an announcement of an outbreak in South Sudan. Africa CDC’s 21 October notice schedules ministerial talks for 28 October 2026. Those talks remain in the future as of this page’s update.
What should people understand about exposure?
WHO describes transmission through direct contact with infected body fluids or contaminated materials. If you feel ill after possible exposure, contact health services promptly and describe the exposure before attending so they can arrange safe care. Follow local health authorities’ instructions.
Frequently asked questions
How current is this Ebola update?
The page was checked on 22 October 2026. Its main case table uses the CDC update published that day, with counts through 21 October. The Nigeria contact figure comes from 20 October. Reporting is incomplete and later figures can change.
Does the map mean all of Africa is affected?
No. It locates selected countries in current reports. It does not show infection across whole countries or equal risk across the continent. Risk depends on location, exposure and the status of local transmission.
Does being a contact mean someone has Ebola?
No. Contacts are people identified for follow-up because they may have been exposed. Monitoring is not a diagnosis, and contacts must not be added to confirmed-case counts.
Is there a vaccine for this outbreak?
WHO states that no vaccine is licensed specifically for Bundibugyo virus disease. Ervebo is licensed for Ebola virus disease caused by a different virus. Research is examining possible protection against Bundibugyo; it is not established protection in humans. Supportive care remains important.
Sources
- CDC situation update, published 22 October 2026; data through 21 October.
- WHO Nigeria: imported case and Nigeria Federal Ministry of Health statement, both 20 October 2026.
- WHO Ebola vaccines Q&A, 9 September 2026; WHO Disease Outbreak News 619, 8 October 2026.
- WHO Ebola disease fact sheet, 24 April 2025; CDC returning-traveler guidance, 11 September 2026. General transmission and safe-care information.
- WHO: DR Congo–South Sudan border surveillance, 22 October 2026.
- Africa CDC: ministerial meeting notice, 21 October 2026; meeting planned for 28 October.
- Map outlines: Natural Earth 1:50m admin-0, v5.1.2, public domain. Country highlighting identifies locations, not infection coverage; no transmission route is implied.
This is a fixed update checked on 22 October 2026. Reports can change as investigations continue. Re-check the linked agencies for later developments.
▶ Explore the seven scenes